Ana K. Stankovic
CIK 1835735 · View on SEC EDGAR ↗
Insider
First SEC filing: May 27, 2021 · Latest: May 27, 2021
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 4 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 25, 2021 | LAB | A | 15,402 | — | — | 15,402 Direct | — | Acquired | (price as of 2026-08-20) |
| May 25, 2021 | LAB | A | 10,342 | — | — | 18,563 Direct | +125.80% | Acquired | (price as of 2026-08-20) |
| Dec. 15, 2020 | LAB | A | 12,237 | — | — | 12,237 Direct | — | Acquired | (price as of 2026-08-20) |
| Dec. 15, 2020 | LAB | A | 8,221 | — | — | 8,221 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 25, 2021 | LAB | Stock Option (Right to Buy) | Common Stock (15,402) | $5.56 | May 25, 2031 | 15,402 | Acquired |
| Dec. 15, 2020 | LAB | Stock Option (Right to Buy) | Common Stock (12,237) | $6.69 | Dec. 15, 2030 | 12,237 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).